ArticleVaccine: X2024
Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in
Intan Aghniya Safitri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleVaccine: X2024
Intan Aghniya Safitri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.